Social media users within Parkinson’s community and beyond, led by BBC journalist Jeremy Vine, have reacted to the death of The Cure Parkinson’s Trust co-founder Tom Isaacs
Emotional outpourings from social media users and Parkinson’s organisations have been published around the world in response to the news that Tom Isaacs, co-founder of The Cure Parkinson’s Trust, died on Wednesday 31 May.
Not long after the news broke, members of Parkinson’s community took to Twitter to pay their respects.
BBC Radio 2 journalist Jeremy Vine led the way, hailing the significance of the “beautiful” Parkinson’s campaigner.
Ann Hanley, founder of the Ann Hanley Parkinson’s Research Fund, revealed that it was Tom Isaacs who inspired her to start her own Parkinson’s organisation.
Ann said: “I am so devastated by the news. Tom was my friend and inspiration. He inspired me to start my own foundation.
“He was a giant among men, a visionary, a dreamer, a man who never gave up, who never quit. He made me laugh and was ever the optimist. I thank God for the privilege of knowing Tom and though saddened by his early demise, he will forever be with me in my thoughts and prayers as I continue to dedicate my life to our common cause.”
The British and Irish Lions, who hosted a charity dinner for The Cure Parkinson’s Trust in April, passed on a message of support.
The British & Irish Lions are very sad to hear the passing of the inspirational Tom Isaacs. https://t.co/e3acUAhKo7
We interviewed Tom to find out more about how the ‘Cure3’ exhibition, a contemporary art exhibition and auction – which included work from Damien Hirst, Grayson Perry and Sarah Lucas – raised money for The Cure Parkinson’s Trust, January 2017.
From a wellness centre to a live mosaic, find out what’s in store
19 hours ago
Could Parkinson’s disease originate in the gut?
A new body of research has highlighted a potential link between gut health and Parkinson’s, with several studies presented at the Society for Neuroscience’s annual meeting in San Diego, US. One study focused on alpha-synuclein – a protein that can cause brain cells to die and contribute to the condition’s onset. As part of the study, the researchers created a mouse model of Parkinson’s by treating the mice with rotenone (an ingredient used in pesticides). This was found to increase clumps of alpha-synuclein in the gut, suggesting the protein may originate in the digestive system before moving to the brain. Commenting on the research presented at the event in a press release, assistant professor of neurosurgery Sonia Villapol said: “When it comes to neurological disorders, we cannot target only the brain. Everything that happens in the gut has an impact on the brain.”
Is dry eye disease common in people with Parkinson’s?
Dry eye disease can involve symptoms such as a lower blinking rate and typically occurs when the eyes are not effectively moistened by tears – leading to discomfort and possible vision loss. Now, a recent study from Japan has investigated the previously underexplored relationship between dry eye disease and Parkinson’s. As part of their research, the team analysed 13 studies published between 2004 and 2022, which involved more than 1,500 people with Parkinson’s. Five of the reports highlighted the prevalence of dry eye disease in people with the condition – with 61% experiencing symptoms. “Our findings emphasize the need for clinicians to be vigilant of the presence of dry eye disease when managing [people with Parkinson’s],” the researchers wrote. However, they noted that more research is needed – especially “future large-scale studies” – to help understand the relationship between dry eye disease and the condition.
Highlighting dental care needs among people with Parkinson’s disease
Researchers from the University of Copenhagen, Denmark, have published a new study looking into dental care among people with Parkinson’s. Using a national register to obtain data relating to dental care between 2015 and 2019, the team identified 6,874 people with Parkinson’s, whose data was then compared to a control group of 34,285 people without the condition. A key takeaway from the five-year study was that a larger portion of people with Parkinson’s were not regular users of the dental care system – 21%, compared to 16.9% in the control group. The findings published in the journal ‘Community Dentistry and Oral Epidemiology’ also revealed that people with Parkinson’s utilised more dental-related treatment services than those in the control group – such as fillings and extractions. The researchers concluded: “This knowledge can be used by clinicians and decision-makers to ensure the optimal dental care for persons with Parkinson’s.”